Imaflex Cost Of Revenue from 2010 to 2024

IFX Stock  CAD 1.49  0.02  1.36%   
Imaflex Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 53.8 M in 2024. During the period from 2010 to 2024, Imaflex Cost Of Revenue regression line of quarterly data had mean square error of 202.7 T and geometric mean of  56,413,433. View All Fundamentals
 
Cost Of Revenue  
First Reported
1999-03-31
Previous Quarter
23.5 M
Current Value
22.5 M
Quarterly Volatility
5.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Imaflex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imaflex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 610.3 K or Total Revenue of 62.7 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0072 or PTB Ratio of 1.61. Imaflex financial statements analysis is a perfect complement when working with Imaflex Valuation or Volatility modules.
  
This module can also supplement various Imaflex Technical models . Check out the analysis of Imaflex Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.